The predominant plasma carrier of hepatic retinol is retinol binding protein 4 (RBP4)
Lipoic Acid as a Potential Therapy for Chronic Diseases Associated with Oxidative Stress Current Medicinal Chemistry, Volume 11, Number 9, 2004, pp
When purchasing either solution, the most important factors are pharmaceutical-grade labeling, a verifiable manufacturer, and proper sealed vial packaging any product that arrives without clear labeling, lot numbers, or expiration dates should be avoided regardless of price
"Tirzepatide versus Insulin Glargine in Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4): A Randomised, Open-Label, Parallel-Group, Multicentre, Phase 3 Trial." The Lancet, 2021, 398(10313), 1811-1824
In addition, Liu et al